{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:85293"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:85293","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"In a bind: targeting PfCLK3 with covalent kinase inhibitors for the treatment of malaria","abstract":"Abstract not currently available.","abstract_html":"Abstract not currently available.","abstract_has_math":false,"creators":["Brettell, Skye"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-19T08:37:12Z","subjects":["QD Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.85293","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.85293","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A85293","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Brettell, Skye"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/85293/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QD Chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.embargoreason","label":"Dc Rights Embargoreason","values":["Other organisation: Keltic Pharma Therapeutics. Please restrict publication of this thesis for 3 years. This thesis contains intellectual property belonging to Keltic Pharma which they wish to remain confidential."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.85293"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Abstract not currently available."]},{"key":"dc:title","label":"Title","values":["In a bind: targeting PfCLK3 with covalent kinase inhibitors for the treatment of malaria"]}]}],"canonical_facts":{"dc:creator":["Brettell, Skye"],"dc:date":["2025"],"dc:date.issued":["2025"],"dc:description.abstract":["Abstract not currently available."],"dc:identifier.doi":["10.5525/gla.thesis.85293"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/85293/"],"dc:rights.embargoreason":["Other organisation: Keltic Pharma Therapeutics. Please restrict publication of this thesis for 3 years. This thesis contains intellectual property belonging to Keltic Pharma which they wish to remain confidential."],"dc:subject":["QD Chemistry"],"dc:title":["In a bind: targeting PfCLK3 with covalent kinase inhibitors for the treatment of malaria"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:37:12Z"}